Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome from Non-Controlling InterestsIncome towards Parent CompanyInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxRevenueSelling, General & AdministrativeTax ProvisionsTax Rate
Others
Ratios

Nutex Health (NUTX) Depreciation & Amortization - Total (2016 - 2018)

Historic Depreciation & Amortization - Total for Nutex Health (NUTX) over the last 9 years, with Q4 2018 value amounting to $432.0.

  • Nutex Health's Depreciation & Amortization - Total rose 4025.97% to $432.0 in Q4 2018 from the same period last year, while for Sep 2019 it was $432.0, marking a year-over-year decrease of 4162.16%. This contributed to the annual value of $14514.0 for FY2020, which is 768.94% down from last year.
  • Latest data reveals that Nutex Health reported Depreciation & Amortization - Total of $432.0 as of Q4 2018, which was up 4025.97% from $432.0 recorded in Q3 2018.
  • Over the past 5 years, Nutex Health's Depreciation & Amortization - Total peaked at $12505.0 during Q2 2016, and registered a low of -$16723.0 during Q4 2016.
  • Its 5-year average for Depreciation & Amortization - Total is $350.21, with a median of $370.0 in 2017.
  • Data for Nutex Health's Depreciation & Amortization - Total shows a peak YoY increase of 267151.52% (in 2016) and a maximum YoY decrease of 1017409.64% (in 2016) over the last 5 years.
  • Over the past 5 years, Nutex Health's Depreciation & Amortization - Total (Quarter) stood at $1192.0 in 2014, then crashed by 86.07% to $166.0 in 2015, then plummeted by 10174.1% to -$16723.0 in 2016, then skyrocketed by 101.84% to $308.0 in 2017, then skyrocketed by 40.26% to $432.0 in 2018.
  • Its Depreciation & Amortization - Total stands at $432.0 for Q4 2018, versus $432.0 for Q3 2018 and $308.0 for Q4 2017.